Skip to main content
. Author manuscript; available in PMC: 2022 Apr 18.
Published in final edited form as: Liver Transpl. 2020 Nov;26(11):1398–1408. doi: 10.1002/lt.25869

FIG. 1.

FIG. 1.

Flow diagram of patients in the study who underwent CACS ± CCTA and post hoc FFRCT analysis. Significant coronary findings on CCTA prompting liver transplantation team notification (n = 8). †There were 15 patients who were on metformin, which would have needed to be held prior to the study; 5 patients did not want to have contrast for research; and 4 procedures could not be performed for logistical reasons.